Propelled by the advancements in bio-artificial kidney technology, the global artificial kidney market has witnessed substantial growth over the past few years. Artificial kidneys are lifesaving medical devices that provide dialysis for patients suffering from chronic kidney disease or end-stage renal disease. Some of the key advantages of artificial kidneys are portability, ability to perform continuous dialysis and more effectively remove toxins compared to conventional dialysis. The growing prevalence of kidney failures coupled with increasing investments in artificial organ development have boosted the demand for advanced dialysis solutions.
The global artificial kidney market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Bio-artificial kidney technology has seen remarkable progress in recent years. Researchers are developing kidney mimicking devices by incorporating natural filtration membranes and functional proteins to enhance cleansing and waste removal. Some of the key players are working on combining stem cell and organ engineering techniques to grow functional kidney tissues in the lab. These next generation bio-engineered kidneys aim to perform all the functions of native kidneys and eliminate the drawbacks of traditional dialysis. If successful, these innovative solutions have the potential to transform kidney disease management and make transplantation redundant for kidney failure patients. Significant investments in kidney regeneration research bode well for the artificial kidney market.
SWOT Analysis
Strength: The artificial kidney market has high growth potential owing to the increasing prevalence of chronic kidney diseases across regions.
Weakness: Development of artificial kidney devices involves high costs requiring extensive research and development.
Opportunity: Advancements in biomaterials and nanotechnology provide opportunities for development of more efficient dialysis solutions.
Threats: Stringent regulatory guidelines for approval of medical devices increase clinical trials duration posing threats from substitutes.
Key Takeaways
The global artificial kidney market is expected to witness high growth. The global artificial kidney market is estimated to be valued at US$ 3358.54 Mn in 2024 and is expected to exhibit a CAGR of 12% over the forecast period 2024 to 2031.
North America is currently dominating the market owing to growing elderly population and increasing incidence of diabetes and hypertension leading to kidney diseases. Asia Pacific is expected to witness fastest growth over the forecast period supported by rising healthcare expenditure, improving healthcare infrastructure and increasing awareness.
Key players operating in the artificial kidney market are KAWASUMI LABORATORIES, INC., Nanodialysis, Fresenius SE & Co KGaA, Baxter, ASAHI KASEI MEDICAL CO., LTD, Medtronic, DaVita Inc, Merit Medical Systems, Nipro Medical Corporation, Nikkiso Co Ltd, Braun Melsungen AG and AWAK Technologies. Fresenius dominated the market. However, technologically advanced products from AWAK Technologies and Nanodialysis are expected to gain significant market share going forward.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
